Chemistry, Manufacturing, and Controls (CMC) in drug development is increasingly critical, yet often built on fragmented tools. Spreadsheets, emails, and siloed data make quality by design in pharma nearly impossible to implement at scale. When key knowledge is scattered, control strategies weaken—and risk creeps in.

Digital platforms transform that.

They centralize your process knowledge and embed QbD into daily operations—linking data, models, and risk control in a live environment. You don’t just define quality; you manage it in real time. These systems link critical quality attributes (CQAs) and critical process parameters (CPPs) across development stages, making risk assessments more reliable and decisions more data-driven.

The result? A more agile process, better compliance, and fewer delays in CMC manufacturing when it matters most.

Curious what CMC in pharma looks like in the digital age?

Discover how quality by design in pharma becomes reality with connected tools.